NCT02210845

Brief Summary

The objective of this study is to investigate whether a behavioral modification intervention in the form of either a 6-month supervised training program or a 6-month financial incentive weight loss program, results in improvement of diabetes outcome such as overall sugar control and lipid control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Jul 2018

Typical duration for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 7, 2014

Completed
3.9 years until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

February 20, 2017

Status Verified

February 1, 2017

Enrollment Period

2.4 years

First QC Date

August 4, 2014

Last Update Submit

February 16, 2017

Conditions

Keywords

DiabetesSupervised ExerciseWeight loss

Outcome Measures

Primary Outcomes (1)

  • Three months average blood glucose (A1c)

    We will assess the effect of supervised training and financially incentivized weight loss on three month average blood glucose in patients with diabetes.

    at 3 months and 6 months

Secondary Outcomes (3)

  • apo B

    6 months

  • systolic blood pressure (SBP)

    3 months and 6 months

  • A1c

    3 months and 6 months

Other Outcomes (4)

  • Composite: Psychosocial outcomes are depressive symptoms, Diabetes specific quality of life

    3 months and 6 months,

  • waist circumference

    3 months and 6 months,

  • weight

    3 months and 6 months,

  • +1 more other outcomes

Study Arms (3)

Financially incentivized weight loss

ACTIVE COMPARATOR

Participants can be assigned to the financially incentivized weight loss group in which they can receive 50 dollars at the end of the month if they achieve their monthly weight loss goal.

Behavioral: Financially incentivized weight Loss

Standard of Care

PLACEBO COMPARATOR

Participants can be assigned to standard of care where they receive no intervention.

Other: Standard Care at BCDiabetes

Supervised Exercise

ACTIVE COMPARATOR

Participants can be assigned to the supervised exercise arm which they will receive supervised professional training once a week.

Behavioral: Supervised exercise

Interventions

Supervised exercise intervention is training with professional trainers once a week. It will include aerobic exercise tailored to the individual participant.

Supervised Exercise

Financially incentivized weight loss encourages participants to achieve a monthly goal weight reduction for a 50 dollars prize.

Financially incentivized weight loss

usual care dictated by GCP at BCDiabetes.ca

Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older.
  • Have been diagnosed with Type 2 diabetes by CDA guidelines.
  • A1c \> 8.0 no more than 30 days prior to randomization and confirmed at the time of randomization.
  • Overweight or obese as defined by BMI of \>25.

You may not qualify if:

  • Have medical co-morbidities that limit their exercise capacity (terminal cancer, severe physical disability such as limb amputation, blindness, seizure disorder, strokes with residual deficits, arrhythmias that would limit physical activity).
  • Alcohol or drug abuse that would interfere with exercise regimen.
  • Cannot read or write English (with the assistance of an interpreter) or are unable to fill out logs and questionnaire.
  • Inability or unwillingness of subject or legal guardian/representative to give written informed consent.
  • Patients for whom an exercise program is deemed medically inadvisable.
  • Patients already enrolled in a supervised training program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver General Hospital

Vancouver, British Columbia, V5Z1M9, Canada

Location

Related Publications (3)

  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. doi: 10.1016/j.diabres.2009.10.007. Epub 2009 Nov 6.

    PMID: 19896746BACKGROUND
  • Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG; American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004 Aug;80(2):257-63. doi: 10.1093/ajcn/80.2.257.

    PMID: 15277143BACKGROUND
  • Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003 Oct;22(5):331-9. doi: 10.1080/07315724.2003.10719316.

    PMID: 14559925BACKGROUND

MeSH Terms

Conditions

Diabetes MellitusWeight Loss

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tom Elliott, MD

    BCDiabetes.Ca

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mandana Moosavi, MDCM

CONTACT

Tom Elliott, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

August 4, 2014

First Posted

August 7, 2014

Study Start

July 1, 2018

Primary Completion

December 1, 2020

Study Completion

December 1, 2021

Last Updated

February 20, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD to other researchers except those involved in the trial

Locations